Safety and immunogenicity of co-administered meningococcal serogroup B (4CMenB) vaccine: A literature review

Safety and immunogenicity of co-administered meningococcal serogroup B (4CMenB) vaccine: A literature review

The four-component meningococcal serogroup B vaccine (4CMenB) is indicated for the prevention of invasive meningococcal disease (IMD) caused by Neisseria meningitidis serogroup B. Co-administering 4CMenB with other vaccines may improve vaccine uptake provided that the safety and immunogenicity of ei...

Full description

Bibliographic Details
Main Authors:	Véronique Abitbol, Woo-Yun Sohn, Michael Horn, Marco Aurelio P. Safadi
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2023-08-01
Series:	Human Vaccines & Immunotherapeutics
Subjects:	4cmenb meningitis b invasive meningococcal disease co-administration concomitant administration
Online Access:	http://dx.doi.org/10.1080/21645515.2023.2245705

Similar Items

Evaluating the effectiveness of the 4CMenB vaccine against invasive meningococcal disease and gonorrhoea in an infant, child and adolescent program: protocol
by: Helen S. Marshall, et al.
Published: (2021-05-01)

A comprehensive review of clinical and real-world safety data for the four-component serogroup B meningococcal vaccine (4CMenB)
by: Gary S. Marshall, et al.
Published: (2023-12-01)

An Observational Study to Assess the Effectiveness of 4CMenB against Meningococcal Disease and Carriage and Gonorrhea in Adolescents in the Northern Territory, Australia—Study Protocol
by: Helen S. Marshall, et al.
Published: (2022-02-01)

Genomic Characterization of Invasive Meningococcal Serogroup B Isolates and Estimation of 4CMenB Vaccine Coverage in Finland
by: Margherita Bodini, et al.
Published: (2020-10-01)

4CMenB Vaccination to Prevent Meningococcal B Disease in Vietnam: Expert Review and Opinion
by: Phung Nguyen The Nguyen, et al.
Published: (2024-03-01)

Evaluation of strain coverage of the multicomponent meningococcal serogroup B vaccine (4CMenB) administered in infants according to different immunisation schedules
by: Alessia Biolchi, et al.
Published: (2019-03-01)

Prediction by genetic MATS of 4CMenB vaccine strain coverage of invasive meningococcal serogroup B isolates circulating in Taiwan between 2003 and 2020
by: Alessandro Muzzi, et al.
Published: (2024-06-01)

High coverage of diverse invasive meningococcal serogroup B strains by the 4-component vaccine 4CMenB in Australia, 2007–2011: Concordant predictions between MATS and genetic MATS
by: Sarah J. Tozer, et al.
Published: (2021-09-01)

Meningococcal B vaccine (4CMenB): the journey from research to real world experience
by: Rino Rappuoli, et al.
Published: (2018-12-01)

Does vaccination with 4CMenB convey protection against meningococcal serogroup B strains not predicted to be covered by MATS? A study of the UK clonal complex cc269
by: Maria Stella, et al.
Published: (2020-04-01)

Evolution of strain coverage by the multicomponent meningococcal serogroup B vaccine (4CMenB) in France
by: Eva Hong, et al.
Published: (2021-12-01)

Available evidence on the co-administration of the four-component meningococcal B vaccine (4CMenB) with three vaccines at the same visit among pediatric individuals
by: Paolo Bonanni, et al.
Published: (2024-12-01)

Modeling the public health impact of different meningococcal vaccination strategies with 4CMenB and MenACWY versus the current toddler MenACWY National Immunization Program in Chile
by: María Gabriela Graña, et al.
Published: (2021-12-01)

4CMenB journey to the 10-year anniversary and beyond
by: Véronique Abitbol, et al.
Published: (2024-12-01)

Social and behavioral predictors of two-doses 4CMenB vaccine series among adolescents enrolled in a cluster randomized controlled trial in Australia
by: Hassen Mohammed, et al.
Published: (2022-01-01)

Persistence of the immune response after 4CMenB vaccination, and the response to an additional booster dose in infants, children, adolescents, and young adults
by: Federico Martinón-Torres, et al.
Published: (2019-12-01)

Genetic characterization and estimated 4CMenB vaccine strain coverage of 284 Neisseria meningitidis isolates causing invasive meningococcal disease in Argentina in 2010–2014
by: Adriana Efron, et al.
Published: (2024-12-01)

The effect of a single 4CMenB vaccine booster in young people more than ten years after infant immunisation: protocol of an exploratory immunogenicity study
by: Kimberly Davis, et al.
Published: (2019-07-01)

Exploiting Real-Time Genomic Surveillance Data To Assess 4CMenB Meningococcal Vaccine Performance in Scotland, 2015 to 2022
by: C. M. C. Rodrigues, et al.
Published: (2023-04-01)

Use of expanded Neisseria meningitidis serogroup B panels with the serum bactericidal antibody assay for the evaluation of meningococcal B vaccine effectiveness
by: Ray Borrow, et al.
Published: (2023-12-01)

Characteristics of YouTube videos about the meningococcal B vaccine (4CMenB)
by: Ignacio Hernández-García, et al.
Published: (2020-10-01)

Cross-reactivity of 4CMenB vaccine-induced antibodies against meningococci belonging to non-B serogroups in Italy
by: Cecilia Fazio, et al.
Published: (2021-07-01)

Emerging experience with meningococcal serogroup B protein vaccines
by: Daniela Toneatto, et al.
Published: (2017-05-01)

University-Based Outbreaks of Meningococcal Disease Caused by Serogroup B, United States, 2013–2018
by: Heidi M. Soeters, et al.
Published: (2019-03-01)

Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B <italic toggle="yes">Neisseria meningitidis</italic> Isolated from 2009 to 2013 in the Republic of Ireland
by: Robert M. Mulhall, et al.
Published: (2018-08-01)

Culture-Confirmed Invasive Meningococcal Disease in Canada, 2010 to 2014: Characterization of Serogroup B <italic toggle="yes">Neisseria meningitidis</italic> Strains and Their Predicted Coverage by the 4CMenB Vaccine
by: Raymond S. W. Tsang, et al.
Published: (2020-04-01)

Serogroup W-135 Meningococcal Disease during the Hajj, 2000
by: Jairam R. Lingappa, et al.
Published: (2003-06-01)

An open-label randomised controlled trial evaluating the efficacy of a meningococcal serogroup B (4CMenB) vaccine on Neisseria gonorrhoeae infection in gay and bisexual men: the MenGO study protocol
by: Caroline Thng, et al.
Published: (2023-03-01)

Serogroup Y Meningococcal Disease, Colombia
by: Clara Inés Agudelo, et al.
Published: (2008-06-01)

Molecular characterization of invasive Neisseria meningitidis isolates collected in Lithuania (2009-2019) and estimation of serogroup B meningococcal vaccine 4CMenB and MenB-Fhbp coverage
by: Emilija Sereikaitė, et al.
Published: (2023-02-01)

Proceedings of the Expert Consensus Group meeting on meningococcal serogroup B disease burden and prevention in India
by: Anand P. Dubey, et al.
Published: (2022-01-01)

Serogroup B Meningococcal Disease Vaccine Recommendations at a University, New Jersey, USA, 2016
by: Heidi M. Soeters, et al.
Published: (2017-05-01)

Genetic Features of a Representative Panel of 110 Meningococcal B Isolates to Assess the Efficacy of Meningococcal B Vaccines
by: Alessandro Muzzi, et al.
Published: (2022-10-01)

Optimizing the timing of 4CMenB vaccination in adolescents and young adults based on immune persistence and booster response data
by: Philip S. Watson, et al.
Published: (2019-04-01)

A critical analysis of serogroup B meningococcal disease burden in Brazil (2001–2015): implications for public health decisions
by: Luciana Andrea Digieri Chicuto, et al.
Published: (2020-08-01)

Adverse reactions associated with meningococcal group B vaccine (4CMenB) in adults in special situations
by: María Fernández-Prada, et al.
Published: (2018-09-01)

Global epidemiology of serogroup B meningococcal disease and opportunities for prevention with novel recombinant protein vaccines
by: Rodolfo Villena, et al.
Published: (2018-05-01)

Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria meningitidis Serogroup B
by: Rivero-Calle I, et al.
Published: (2019-10-01)

Increase in Meningococcal Serogroup W Disease, Victoria, Australia, 2013–2015
by: Kylie S. Carville, et al.
Published: (2016-10-01)

[Meningococcal meningitis: a case of serogroup W in an underage migrant]
by: Silvia Dari, et al.
Published: (2017-06-01)